Mergus Ventures

Mergus Ventures is a Brazilian venture capital firm dedicated to investing in unconventional founders who are addressing challenges with cutting-edge, future-forward technologies. The firm focuses on innovations that push the boundaries of the planet and humanity, seeking opportunities where the interaction between humans and machines redefines markets and experiences. By investing in behaviors that are shaping the present and will continue transforming the future, Mergus Ventures aims to drive structural changes in products and the way the world connects.

The firm's investment strategy emphasizes sectors such as biotechnology, 3D technology, medical life sciences, therapeutics, and 3D printing. Mergus Ventures targets various stages of investment, including seed, early stage, Series A, Series B, growth, late stage, and pre-IPO, with investment sizes ranging from $100,000 to $1,000,000. The firm's geographical focus is primarily on Brazil, aligning with its mission to support innovative startups within the country.

Mergus Ventures has a track record of investing in startups with high growth potential, having made 18 investments totaling approximately R$ 40 million since its inception in 2021. The firm has also set a goal to invest R$ 60 million in startups by 2025, demonstrating its commitment to fostering innovation and entrepreneurship in Brazil. Notable portfolio companies include TissueLabs, HyLight, Invitris, Spaceium, ZeroPath, Weave, Conductor Quantum, Mooney, Jusfy, Starcloud, and Done Properly. These investments reflect Mergus Ventures' dedication to supporting visionary companies that are shaping the future through technological advancements.